Hereditary iron overload: Update on pathophysiology, diagnosis, and treatment

American Journal of Hematology

Volumn 81, Issue 3, 2006, Pages 202-209

  Franchini, Massimo ^a,b  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b OSPEDALE POLICLINICO   (Italy)

Author keywords

Genetics; Hereditary hemochromatosis; HFE gene; Iron overload

Indexed keywords

ERYTHROPOIETIN; FERROPORTIN 1; GENE PRODUCT; HFE PROTEIN; IRON; IRON CHELATING AGENT;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CAUCASIAN; CHROMOSOME 1; CHROMOSOME 19; CHROMOSOME 3; CHROMOSOME 6; CLINICAL FEATURE; FERROPORTIN 1 GENE; GENE MUTATION; HAMP GENE; HEART TRANSPLANTATION; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS TYPE 1; HEREDITARY HEMOCHROMATOSIS TYPE 2; HEREDITARY HEMOCHROMATOSIS TYPE 3; HEREDITARY HEMOCHROMATOSIS TYPE 4; HFE GENE; HJV GENE; HUMAN; HUMAN GENOME; IRON OVERLOAD; PHLEBOTOMY; PRIORITY JOURNAL; SHORT SURVEY; TFR2 GENE;

ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; CHROMOSOMES, HUMAN; GENES, DOMINANT; GENES, RECESSIVE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MEMBRANE PROTEINS; RECEPTORS, TRANSFERRIN;

EID: 33644504859     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20493     Document Type: Short Survey

References (84)

1. Merryweather-Clarke AT, Pointon JJ, Sherman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-278.
2. Worwood M. Inherited iron loading: genetic testing in diagnosis and management. Blood Rev 2005;19:69-88.
3. Franchini M, Veneri D. Recent advances in hereditary hemochromatosis. Ann Hematol 2005;84:347-52.
4. Camaschella C, De Gobbi M, Roetto A. Hereditary hemochromatosis: progress and perspectives. Rev Clin Exp Hematol 2000; 4:302-321.
5. Pietrangelo A. Haemochromatosis. Gut 2003;52:23-30.
6. Pietrangelo A. Non-HFE hemochromatosis. Hepatology 2004; 39:21-29.
7. Bomford A. Genetics of haemochromatosis. Lancet 2002;360: 1673-1681.
8. Pietrangelo A, Camaschella C. Molecular genetics and control of iron metabolism in hemochromatosis. Haematologica 1998;83:456-461.
9. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 2004;350:2383-2397.
10. Hemochromatosis. In: Online Mendelian Inheritance in Man, OMIM. Baltimore: McKusick-Nathans Institute for Genetic Medicine; 2000 (http://www.ncbi.nlm.nih.gov/omim/).
11. Limdi JK, Crampton JR. Hereditary hemochromatosis. Q J Med 2004;97:315-324.
12. Andrews NC. Molecular control of iron metabolism. Best Pract Res Clin Haematol 2005;18:159-169.
13. Cazzola M. Hereditary hyperferritinaemia/cataract syndrome. Best Pract Res Clin Haematol 2002;15:385-398.
14. Simon M, Pawlotsky Y, Bourel M, Fauchet R, Genetet B. Hémochromatose idiopathique maladie associáe à l'antigene tissulaire HL-A 3. Nouv Presse Med 1975;4:1432.
15. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis: demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med 1977;297:1017-1021.
16. Simon M, Le Mignon L, Fauchet R, et al. A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association. Am J Hum Genet 1987;41:89-105.
17. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
18. Waalen J, Nordestgaard BG, Beutler E. The penetrance of hereditary hemochromatosis. Best Pract Res Clin Haematol 2005;18:203-220.
19. Cazzola M. Novel genes, proteins, and inherited disorders of iron overload: iron metabolism is less boring than thought. Haematologica 2002;87:115-116.
20. Brissot P, Moirand R, Jouanolle AM, et al. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J Hepatol 1999;30:588-593.
21. Carella M, D'Ambrosio L, Totaro A, et al. Mutation analysis of HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997;60:828-832.
22. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82.
23. Piperno A, Sampietro M, Pietrangelo A, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002.
24. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KIH. Geography of HFE C282Y and H63D mutations. Genet Test 2000;4:183-198.
25. Hanson EH, Imperatore G, Burke W. HFE gene and hemochromatosis: a HuGE review. Am J Epidemiol 2001;154:193-206.
26. Mura C, Raguenes O, Férec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93:2502-2505.
27. Rochette J, Pointon JJ, Fisher CA, et al. Multicentric origin of hemochromatosis gene (HFE) mutations. Am J Hum Genet 1999;64:1054-1062.
28. Candore G, Mantovani V, Balistreri CR, et al. Frequency of the HFE gene mutations in five Italian populations. Blood Cells Mol Dis 2002;29:267-273.
29. Camaschella C, Roetto A, De Gobbi M. Genetic haemochromatosis: genes and mutations associated with iron loading. Best Pract Res Clin Haematol 2002;15:261-276.
30. Zoller H, Pietrangelo A, Vogel W, Weiss G. Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary hemochromatosis. Lancet 1999;353:2120-2123.
31. Donovan A, Brownlie A, Zhou H, et al. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 2000;403:776-781.
32. Pietrangelo A. Physiology of iron transport and the HFE gene. Am J Physiol 2002;282:6403-6407.
33. Waheed A, Parkkila S, Saamio J, et al. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci U S A 1999;96:1579-1584.
34. Roetto A, Papanikolaou G, Politou, M. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-22.
35. Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 2005;18:171-182.
36. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol 2004;11:251-254.
37. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-7810.
38. Frazer DM, Wilkins SJ, Becker EM, et al. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 2002;123: 835-844.
39. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-788.
40. Ahmad KA, Ahmann JR, Migas MC, et al. Decreased liver hepcidin expression in the FHE knockout mice. Blood Cells Mol Dis 2002;29:361-366.
41. Gehrke SG, Kulaksiz H, Hermann T, et al. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 2003;102:371-378.
42. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated hemochromatosis and the liver as a regulator of body iron homeostasis. Lancet 2003;361:669-673.
43. Nicolas G, Viatte L, Lou DQ, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003;34:97-101.
44. Merryweather-Clarke AT, Cadet E, Bomford A, et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 2003;12:2241-2247.
45. Barton JC, McDonnell S, Adams P. Management of hemochromatosis. Ann Intern Med 1998;129:932-939.
46. Piperno A. Classification and diagnosis of iron overload. Haematologica 1998;83:447-455.
47. Powell LW, George DK, McDonnel SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998;129:925-931.
48. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary hemochromatosis mutation in the USA. Lancet 2002;359:211-218.
49. Robson KJH, Merryweather-Clarke AT, Cadet E, et al. Recent advances in understanding hemochromatosis: a transition state. J Med Genet 2004;41:721-730.
50. Asberg A, Thorstensen K, Hveem K, Bjerve KS. Hereditary hemochromatosis: the clinical significance of the S65C mutation. Genet Test 2002;6:59-62.
51. Holmstrom P, Marmur J. Eggertsen G, Gafvels M, Stal P. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 2002;51:723-730.
52. Piperno A, Arosio C, Fossati L, et al. Two novel mutations of HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology 2000;119:441-445.
53. Salvioni A, Mariani R, Oberkanins C, et al. Prevalence of C282Y and E168X HFE mutations in an Italian population of Northern European ancestry. Haematologica 2003;88:250-255.
54. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the hemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-323.
55. Sampietro M, Piperno A, Lupica L, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998;27:181-184.
56. Borgna-Pignatti C, Solinas A, Bombieri C, et al. The hemochromatosis mutations do not modify the clinical picture of thalassemia major in patients regularly transfused and chelated. Br J Haematol 1998;103:813-816.
57. Longo F, Zecchina G, Sbaiz L, Fischer R, Piga A, Camaschella C. The influence of hemochromatosis mutations on iron overload of thalassemia major. Haematologica 1999;84:799-803.
58. Piperno A, Mariani R, Arosio C, et al. Haemochromatosis in patients with β-thalassemia trait. Br J Haematol 2000;111:908-914.
59. Melis MA, Cau M, Deidda F, Barella S, Cao A, Galanello R. H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers. Haematologica 2002;87:242-245.
60. Zanella A, Bianchi P, Iurlo A, et al. Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases. Blood Cells Mol Dis 2001;27:653-661.
61. Njajou O, Behrooz ZA, van Duijn CM. Is genetic screening for hemochromatosis worthwhile? Eur J Epidemiol 2004;19:101-108 (review).
62. Guyader D, Jacquelinet C, Moirand R, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-936.
63. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986;6:24-29.
64. Nielsen P, Engelhardt R, Dullmann J, Fischer R. Non-invasive liver iron quantification by SQUID-biosusceptometry and serum ferritin iron as new diagnostic parameters in hereditary hemochromatosis. Blood Cells Mol Dis 2002;29:451-458.
65. Brittenham GM, Badman DG, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Workshop. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003;101:15-19.
66. McDonnel SM, Preston BL, Jewell SA, et al. A survey of 2851 patients with hemochromatosis: symptoms and response to treatment. Am J Med 1999;106:619-624.
67. Franchini M, Gandini G, Aprili G. Advances in iron chelating therapy. Haematologica 2000;85:1122-1125.
68. Franchini M, Veneri D. Iron-chelation therapy: an update. Hematol J 2004;5:287-292.
69. Franchini M, Gandini G, de Gironcoli M, Vassanelli A, Borgna-Pignatti C, Aprili G. Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload. Blood 2000;95:2776-2779.
70. Camaschella C, Roetto C, De Gobbi M. Juvenile hemochromatosis. Semin Hematol 2002;39:242-248.
71. De Gobbi M, Roetto A, Piperno A, et al. Natural history of juvenile haemochromatosis. Br J Haematol 2002;117:973-979.
72. Cazzola M. Genetic disorders of iron overload and the novel "ferroportin disease." Haematologica 2003;88:721-724.
73. Roetto A, Totaro A, Cazzola M, et al. Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet 1999;64: 1388-1393.
74. Roetto A, Camaschella C. New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis. Best Pract Res Clin Haematol 2005;18:235-250.
75. Lanzara C, Roetto A, Daraio F, et al. Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 2004;103:4317-4321.
76. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15.
77. Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999;274:20826-20832.
78. Njajou OT, Vaessen N, Joosse M, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-214.
79. Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis 2004;32:131-138.
80. Cazzola M. Role of ferritin and ferroportin genes in unexplained hyperferritinaemia. Best Pract Res Clin Haematol 2005;18: 251-263.
81. Devalia V, Carter K, Walker AP, et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 2002; 100:695-697.
82. Montosi G, Donovan A, Totano A, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-623.
83. Roetto A, Merryweather-Clarke AT, Daraio F, et al. A valine deletion of ferroportin 1: a common mutation in hemochromatosis type 4. Blood 2002;100:733-734.
84. Wallace DF, Pedersen P, Dixon JL, et al. Novel mutation in ferroportin 1 is associated with autosomal dominant hemochromatosis. Blood 2002;100:692-694.